Interview, Fireside Chat, Keynote
Vitamin D Expert: The Fastest Way To Dementia & The Big Lie About Sunlight!
- Stephen Bartlett anticipates that verifying subscription status will maintain the show's current trajectory and historical viewer engagement, while the "Diary of a CEO Inner Circle" private community aims to provide direct access to the host and member influence over future content.
- Access to the "Diary of a CEO Inner Circle" prior to the first 10,000 spots filling is predicted to grant members exclusive briefs, unreleased clips, and behind-the-scenes content.
- Dr. Roger Seholt identifies staff compliance as the primary barrier to his plan to work across three hospitals to move patients outdoors, a shift he predicts would create a "win-win-win" scenario involving improved patient surveys and hospital reimbursement.
- Seholt expects that returning to "turn of the century" hospital designs allowing beds on verandas for sunlight exposure, or placing patients in rooms with windows, will accelerate patient discharge times.
- He predicts that increased time spent in green spaces will reduce diabetes, hypertension, and mortality rates, citing the Green Heart Study as evidence that tree planting lowers HSCRP levels independent of socioeconomic status or exercise.
- Seholt anticipates that phytoncides from trees like Hinoki cypress will increase natural killer cell numbers and disease-breaking enzymes with benefits lasting approximately seven days, and that visiting nature one day a week can elevate the immune system and induce relaxation.
- He warns that staying indoors or looking through modern windows is not a replacement for going outside, as modern glass reduces infrared light; he expects infrared exposure via devices like red light masks or 670-nanometer red light eye therapy for three minutes each morning to improve collagen deposition, skin tightness, and visual perception.
- Seholt predicts that deaths from cardiac, respiratory, kidney, and infectious diseases will peak within one month after the winter solstice in the Northern Hemisphere, noting that workers on 7 a.m. to 7 p.m. shifts during December and January may go weeks without sun exposure.
- He forecasts that the "Dark Days and Bright Nights" lifestyle correlates with increased mortality compared to "bright days and dark nights," and expects people living at high latitudes with darker skin to require more outdoor time for sufficient vitamin D production.
- Seholt predicts that supplementing with 2,000 international units of vitamin D daily will lower the risk of autoimmune conditions like rheumatoid arthritis and Crohn's disease, though he notes risks of calcium metabolism issues if excessive amounts are taken and concerns that LED lighting exposes humans to a narrower, less beneficial light spectrum than historical incandescent bulbs.
- He expects switching from LED to incandescent bulbs could improve worker color differentiation by approximately 25% and predicts that sleeping with eyelids closed in light-polluted environments may still suppress melatonin, making sleep masks beneficial.
- Seholt anticipates that using Kindle or similar screen devices at night will delay sleep onset and shut down melatonin more significantly than reading a book with a lamp, while taking large doses of melatonin routinely may cause mental irritability.
- He suggests that spending four to seven weeks per week in saunas will result in fewer cardiovascular deaths compared to once-weekly use, and that adding cold water therapy triggers vasoconstriction and white blood cell demargination.
- Seholt expects that maintaining strong organ systems is superior to medication for longevity, and that a good faith relationship with a deity aids in coping with stress, depression, and anxiety, whereas a vindictive relationship with a deity is negatively impactful on health.
- He predicts that individuals who believe God has forgiven them are 2.5 times more likely to forgive others unconditionally, and that integrating faith aspects into cognitive behavioral therapy may enhance its effectiveness in a randomized placebo-controlled setting.